Cellular accumulation, localization, and activity of a synthetic cyclopeptamine in fungi

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 2, 1998, Pages 389-393

  Capobianco, John O ^a   Zakula, Dorothy ^a   Frost, David J ^a   Goldman, Robert C ^a   Li, Leping ^a   Klein, Larry L ^a   Lartey, Paul A ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BETA GLUCAN SYNTHASE INHIBITOR; A 172013; CYCLOPEPTAMINE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CELL INTERACTION; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG ACTIVITY; DRUG DIFFUSION; DRUG DISTRIBUTION; DRUG PENETRATION; MEMBRANE BINDING; NONHUMAN; PASSIVE TRANSPORT; PRIORITY JOURNAL;

CANDIDA ALBICANS; CELL WALL; GLUCANS; MICROSOMES; PEPTIDES, CYCLIC; PROTOPLASTS;

EID: 0031938066     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Ahlström, B., M. Chelminska-Bertilsson, R. A. Thompson, and L. Edebo. 1997. Subcellular complexes may initiate the fungicidal effects of cationic amphiphilic compounds on Candida albicans. Antimicrob. Agents Chemother. 41:544-550.
2. Arnezeder, C., and W. A. Hampel. 1990. Influence of growth rate on the accumulation of ergosterol in yeast-cells. Biotcchnol. Lett. 12:277-282.
3. Balkovec, J. M. 1994. Lipopeptide antifungal agents. Expert Opin. Invest. Drugs 3:65-82.
4. Beaulieu, D., J. Tang, S. B. Yang, J. M. Vessels, J. A. Radding, and T. R. Parr, Jr. 1994. Characterization and cilofungin inhibition of solubilized Aspergillus fumigatus (1,3)-β-D-glucan synthase. Antimicrob. Agents Chemother. 38:937-944.
5. Capobianco, J. O., C. C. Doran, and R. C. Goldman. 1989. Mechanism of mupirocin transport into sensitive and resistant bacteria. Antimicrob. Agents Chemother. 33:156-163.
6. Capobianco, J. O., and R. C. Goldman. 1990. Erythromycin and azithromycin transport into Haemophilus, influenzae ATCC 19418 under conditions of depressed proton motive force (Δμ̃H). Antimicrob. Agents Chemother. 34: 1787-1791.
7. Capobianco, J. O., D. Zakula, M. L. Coen, and R. C. Goldman. 1993. Anti-Candida activity of cispentacin: the active transport by amino acid permeases and possible mechanisms of action. Biochem. Biophys. Res. Commun. 190:1037-1044.
8. Cassone, A., R. E. Mason, and D. Kerridge. 1981. Lysis of growing yeast-form cells of Candida albicans by echinocandin: a cytological study. Sabouraudia 19:97-110.
9. De Lean, A., P. J. Munson, and D. Rodbard. 1978. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol. 235:E97-E102.
10. Espinel-Ingroff, A., C. W. Kish, Jr., T. M. Kerkering, R. A. Fromtling, K. Bartizal, J. N. Galgiani, K. Villareal, M. A. Pfaller, T. Geraden, M. G. Rinaldi, and A. Fothergill. 1992. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J. Clin. Microbiol. 30:3138-3145.
11. Fasoli, M. O. F., and D. Kerridge. 1990. Uptake of pyrimidines and their derivatives into Candida glabrata and Candida albicans. J. Gen. Microbiol. 136:1475-1481.
12. Frost, D. J., K. Brandt, J. Capobianco, and R. Goldman. 1994. Characterization of (1,3)-β-glucan synthase in Candida albicans: microsomal assay from the yeast or mycelial morphological forms and a permeabilized whole-cell assay. Microbiology 140:2239-2246.
13. Frost, D. J., K. Brandt, C. Estill, and R. Goldman. 1997. Partial purification of (1,3)-β-glucan synthase from Candida albicans. FEMS Microbiol. Lett. 146:255-261.
14. Frost, D. J., M. Knapp, K. Brandt, A. Shadron, and R. C. Goldman. 1997. Characterization of a lipopeptide-resistant strain of Candida albicans. Can. J. Microbiol. 43:122-128.
15. Georgopapadakou, N. H., and T. J. Walsh. 1996. Antifungal agents: chemotherapeutic targets and immunologic strategies. Antimicrob. Agents Chemother. 40:279-291.
16. Goldman, R. C., D. J. Frost, J. O. Capobianco, S. Kadam, R. R. Rasmussen, and C. Abad-Zapatero. 1995. Antifungal drug targets: Candida secreted aspartyl protease and fungal wall β-glucan synthesis. Infect. Agents Dis. 4:228-247.
17. Herbette, L. G., A. M. Katz, and J. M. Sturtevandt. 1983. Comparison of the interaction of propranolol and timolol with model and biological membranes. Mol. Pharmacol. 24:259-269.
18. Jones, L., C. Hobden, and P. O'Shea. 1995. The use of a real-time probe of the electrostatic properties of the cell surface of Candida albicans. Mycol. Res. 99:969-976.
19. Jones, L., and P. O'Shea. 1994. The electrostatic nature of the cell surface of Candida albicans: a role in adhesion. Exp. Mycol. 18:1-10.
20. 2 and its reaction products. Biochim. Biophys. Acta 1193:31-40.
21. Ko, Y.-T., R. D. Ludescher, D. J. Frost, and B. P. Wasserman. 1994. Use of cilofungin as direct fluorescent probe for monitoring antifungal drug-membrane interactions. Antimicrob. Agents Chemother. 38:1378-1385.
22. Kurtz, M. B., C. Douglas, J. Marrinan, K. Nollstadt, J. Onishi, S. Dreikorn, J. Milligan, S. Mandala, J. Thompson, J. M. Balkovec, F. A. Bouffard, J. F. Dropinski, M. L. Hammond, R. A. Zambias, G. Abruzzo, K. Bartizal, O. B. McManus, and M. L. Garcia. 1994. Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis. Antimicrob. Agents Chemother. 38:2750-2757.
23. Kurtz, M. B., and C. Douglas. 1997. Lipopeptide inhibitors of fungal glucan synthase. J. Med. Vet. Mycol. 35:79-86.
24. Kurtz, M. B., I. B. Heath, J. Marrinan, S. Dreikorn, J. Onishi, and C. Douglas. 1994. Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-β-D-glucan synthase. Antimicrob. Agents Chemother. 38:1480-1489.
25. Li, L., S. Thomas, D. J. Grampovnik, L. L. Klein, D. DeGoey, H.-J. Chen, C. M. Yeung, C. Leone, C. Curty, D. Frost, A. Nilius, J. Meulbroek, P. A. Lartey, and J. J. Plattner. 1997. Synthesis and antifungal activities of cyclopeptamines. Novel cell wall synthesis inhibitors, abstr., F-238, p. 186. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
26. Mason, R. P., J. Moring, and L. G. Herbette. 1990. A molecular model involving the membrane bilayer in the binding of lipid soluble drugs to their receptors in heart and brain. Nucl. Med. Biol. 17:13-33.
27. McCloskey, M. A., and M.-M. Poo. 1986. Rates of membrane-associated reactions: reduction of dimensionality revisited. J. Cell Biol. 102:88-96.
28. Pfaller, M. A., J. Riley, and T. Koerner. 1990. Effects of terconazole and other azole antifungal agents on the sterol and carbohydrate composition of Candida albicans. Diagn. Microbiol. Infect. Dis. 13:31-35.
29. Rhodes, D. G., R. Newton, R. Butler, and L. Herbette. 1992. Equilibrium and kinetic studies of the interactions of salmeterol with membrane bilayers. Mol. Pharmacol. 42:596-602.
30. Taft, C. S., T. Stark, and C. P. Selitrennikoff. 1988. Cilofungin (LY121019) inhibits Candida albicans (1-3)-β-D-glucan synthase activity. Antimicrob. Agents Chemother. 32:1901-1903.
31. Taft, C. S., and C. P. Selitrennikoff. 1990. Cilofungin inhibition of (1,3)-β-glucan synthase: the lipophilic side chain is essential for inhibition of enzyme activity. J. Antibiot. 43:433-437.
32. Tkacz, J. S. 1992. Glucan biosynthesis in fungi and its inhibition, p. 495-523. In J. A. Sutcliffe and N. H. Georgopapadakou (ed.), Emerging targets in antibacterial and antifungal chemotherapy. Chapman and Hall, New York, N.Y.